Friday, October 19, 2012

Honeywell (HON) Q3 earnings release


Honeywell came out with a good quarter in beating analysts’ estimates for a fifth quarter in a row. Having an increase in EPS of 9% to $1.20 from $1.10 it blew past estimates of 1.14 for the company. Sales for the company as a whole had a pretty shallow growth of 2% to 9.34 billion which were below estimates, but with a segment profit increase of 8% with a margin percentage increase of 110 basis points. With Net Income having a 10% increase from $862M in Q3 2011 to $920M in Q3 2012 the company has proven its investments in new products and high growth regions, such as natural gas, and a balanced mix of long- and short-term business cycles was able to offset their European weaknesses, lower demand for short-cycle products in China and the U.S., and foreign exchange headwinds in the future.  Also stating a sense of confidence with maintaining a strong backlog with new platform wins across many of their different sectors.
Their guidance for sales and EPS were a little mixed, having lowered and narrowed their sales guidance outlook by 3% versus 2011 with a drop from $37.8-38.4B to $37.5-37.7B. However, they narrowed and increased their EPS guidance by 10% versus 2011 from $4.40-$4.55 to $4.45-4.50.

Following the earnings release, stock price closed today $62.49, a growth of 1.74% breaking through the $62.00 ceiling that seemed to be a resistance point for the year.   Following their acquisition Thomas Russell in their UOP segment, CEO Dave Cote placed a strong emphasis on natural gas investment which seems to be the way with the future outlook of coal depleting.

Different sectors: Q4 2012 outlook (primary causes)

Aerospace- 0%-(2)% reduction because of defense program ramp downs.

Automation and Controls Solution- 1%-3% growth because of increased investments for growth and   productivity yielding strong sales conversion.

Performance Materials and Technologies- 4%-6% growth because of UOP acquisition of Thomas Russell in the natural gas sector.

Transportation- (8)%-(12)% reductions because of EU light vehicle production down (–9%)

Honeywell Overall-
0%-1% ; Total $9.4-$9.6B      

Baxter International (BAX) Q3 Earnings Release

Baxter International released Q3 earnings this past Thursday, 10/18. 

Full year EPS guidance was narrowed as management trimmed off the top and increased the bottom of FY EPS expectations. They now expect FY$4.51-$4.54 a share, versus $4.49-$4.57. This will represent an increase of ~15% versus 2011. For Q3, BAX brought in an adjusted EPS of $1.14 per diluted share, a slight increase of 5% from Q3 2011. Management expects Q4 EPS to fall within $1.24 to $1.27. This falls within analyst expectations of $1.26 per share from $3.71 Billion in revenue. 

Total revenues for the quarter were $3.5 billion, near flat with Q3 2011.
• Global Bioscience: $1.5 Billion (+5% vs 2011) 
• Medical products: $2 Billion (0% vs. 2011) 

Gross margin improved to 52.1%, the strongest it has been in 3 years. Expectations are that it will continue to grow for full year. 

Net income rose to $583 Million from $573 Million last year. 

Management guidance for full year 2012 was largely conservative at a 5% growth rate, however they predict that macro effects and exchange rate issues will erode that to roughly 2%. Moving forward, BAX wants to continue to leverage their current product portfolio in new markets while trying to expand into “unmet medical needs. “

Following Q3 earnings, BAX shares rose above our price target of 61.90 to close at $62.08. Because of the price target being met, the model will be revised for a new target price and thesis by next Monday

Thursday, October 18, 2012

BlackRock (BLK) Q3 Earnings Release


BlackRock reported Q3 2012 earnings of $3.65 per share, this beat consensus estimates of analysts that projected $3.32. BlackRock had several key themes throughout the quarter that drove the beat. Assets under management (AUM) grew to $3.673 Trillion; a 10% improvement over the same period ended a year prior. Also, contributing to strong revenue during the quarter were iShares posting the strongest quarter of inflows since 2009.  This included notable inflows into equity ETFs, not seen for some time. 
Revenue had a strong quarter improving 4% from Q2 2012, but expense management was a main highlight for BlackRock during the Q3. BlackRock’s operating margin improved to 37.7% a substantial increase over Q3 of 2011, which had a 34.9% operating margin.

BlackRock completed its acquisition of Swiss Re Private Equity Partners during September, which contributed the AUM improvement. Management decided to repurchase 960,100 shares during the quarter (8.2 million YTD), which was expected.

Earnings call discussion included the continued theme of price competition in the industry, following BlackRock’s disclosure earlier in the week that iShares ETF fees will be lowered to response to market pressure. This pressure mainly comes from competitor, Vangaurd. Our expectations regarding lower fees on ETFs is that improved AUM will offset the losses in the medium term.  Going forward BlackRock expects competitors to raise their fees modestly because they are barely breaking even on their products. BlackRock will launch TV advertisements for the first time to help combat growing competition; we expect this strategy to be successful and representative of BlackRock’s already strong brand position.

How our estimates compared: Revenue was inline with our expectations. Expenses were slightly under by 1%. Net income was 15% above our expectations, due to a favorable tax rate on the quarter. Diluted EPS beat our estimates by 16%; we projected EPS of $3.14 vs. $ 3.65 actual. We are currently projecting EPS of $3.42 for Q4 and EPS of $13.30 for Full Year 2012.

Looking forward we expect AUM inflows to be strong during Q4, paying special attention to iShares fee changes and how margins are impacted in that segment going forward. 

Wednesday, October 17, 2012

RS Sell Thesis

Today we sold all of our 90 shares of Reliance Steel (RS) at the price of $53.52. This represents a loss of 3.85%. The company continues to do well, but it is not reflective in their stock price. This is a great example of a great company, but a bad stock. We bought in at the tail end of a 40% upswing and the stock plateaued after we bought it. The thesis when we originally bought this stock was based on improving steel demand and steel pricing. While this thesis held true for a few months, it turned for the worse and the steel industry as a whole suffered. The steel industry currently is not doing well due to a very high supply, but weakening  demand. This is driving prices down which is hurting all companies throughout the industry. A big driver of the industry is China because they have a very high demand for steel. With their economy currently slowing, it is hurting the steel industry as whole, even companies with minimal exposure such as Reliance Steel. RS has beat estimates for the first and second quarters of this year, but in the last conference call, management lowered guidance for the second half of the year, which was slightly below the streets estimates. So I felt as if this was a good time to sell out with minimal losses. The stock usually does better in the first two quarters and then regresses. If the stock becomes favorable again at a lower price before the first quarter of 2013, it may be a good opportunity to buy back in.

-John Astarita

Friday, October 12, 2012

OZRK Q3 Earnings

OZRK released earnings last night after market close. Net Income was 19.3 million, up 2% from Q3 last year. EPS was .55, in line with estimates and unchanged from last year. Legacy loan portfolio grew 9.1% to 2.03 billion from 1.86 billion while total loans (including loss share loans) dropped 1.4%. Deposits were down 5.1% to 2.89 billion Assets were 3.82 billion down from 3.93 billion Q3 2011. Stockholders' equity was up 17.4% to 478 million. Net interest income was up only .2% to $44.4 million over last year. Non-interest income declined almost 10% to 14.5.
Over all, these results are not fantastic, but not bad. The market responded with a 4% drop in price today. I will incorporate these into my model, but I don't forsee a significant change in my target price of $35.77. I believe the market got overly excited after last quarter's performance and had anticipations a little too high, and I believe the stock will rebound.

Honeywell acquisition of Thomas Russell

UOP, a Honeywell company in their Performance Materials and Technologies sector, recently acquired a 70% stake in Thomas Russell Co. for $525 million and also have rights to purchase the remaining 30%, which raised its involvement in natural gas processing.  Thomas Russel was a privately held, leading provider of technology and equipment for natural gas and processing and treatment.  With this acquisition, Honeywell will be able to provide shale and conventional natural gas companies with a broad range of technology and equipment to remove contaminants from natural gas and produce high quality natural gas liquids used for petrochemical and fuel.

This is a significant purchase in that they are investing the natural gas market and seeing the possibilities of growth.  With the agreement between ConocoPhillips, BP and TransCanada Corp. of building the pipeline between Alaska and Asia, this is definitely an emerging market that has much prospect for future growth.  Natural gas is not just showing growth for a few years ahead but rather for decades to come so I feel very positive about Honeywell's actions of trying to break into this market.  After this acquisition, Dave Cote stated in an interview, "We will keep making acquisitions in natural gas and invest in the UOP unit to develop new gas technology," Cote said, "I'm a big believer in natural gas and in what it can do for the U.S. economy and many economies around the world." With this, I see Honeywell only as a hold rather than a buy currently, as the UOP division is still only a small segment of their whole enterprise.

Thursday, October 4, 2012

OZRK Acquisition of Genala Bank

OZRK announced after market close today that they have entered into a $27.3 million agreement with Genala Bank which operates The Citizens Bank (not to be confused with Citizen's Bank), a one-office bank in Geneva, Alabama.This announcement marks a first for Ozarks as it is not an FDIC-assisted acquisition, but rather that of traditional M&A. OZRK CEO called the company "a healthy bank with solid market share," which makes for an entirely different situation from the failed banks they have purchased in recent years. OZRK will be issuing $13.9 million in stock and paying $13.4 million cash in exchange for all outstanding Genala shares. As of Q2 2012, Genala carried approximately $170 million in total assets, $45 million in loans, and $142 million deposits on its balance sheet. However, other financial statement information is not available. This transaction is expected to close late December of this year or early Q1 2013. This acquisition was unanimously approved on both sides.

OZRK has a history of making sound decisions and investments, and clearly they believe that this will have a net benefit to the company, but this is a difficult transaction to analyze. Very much on the surface, OZRK is exchanging $27.3 million in assets and equity for $28 million in net assets, which sounds like a good deal. However, a lot of information is not available, like the quality of the loan underwriting and the deposit mix can make a huge difference. Having deposits more than 3x loans has to be a significant drag on net interest income and margin. The combined Q2 balance sheet represents $3.9 billion assets with $2.7 billion loans and $2.9 billion deposits, which is 1.08x loans. On their own, OZRK's deposits are 1.06x loans and their net interest margin significantly surpasses peers at almost 6% (most peers weigh in around 3.5%), which is even more impressive in the current interest rate environment. With OZRK's size, I think the loan/deposit mix is still reasonably balanced, although I certainly expect some negative impact on net interest income and margin.

I expect a dip in OZRK share price tomorrow in response to the news, but I think it will be largely superficial, particularly considering that OZRK reports Q3 earnings next Thursday. Last quarter, OZRK stock climbed nearly 9% in the day following earnings. This timing is advantageous, and no doubt strategic.

Without more information, I am not sure whether to anticipate net gains or losses from this acquisition, although I expect net gains are far more likely. OZRK closed at 34.12 and my current price target is 35.77, although that will be revised post-earnings. I certainly maintain my hold position through the earnings release, at which point the model will be updated and the price target revised.